News
The Canadian Press on MSN4d
Telus CEO decries 'race to the bottom' through price matching with competitorsTelus Corp. raised its quarterly dividend as it reported its first-quarter profit rose compared with a year ago.
Match Group, Inc.'s Q1 results reveal Tinder's struggles with declining paid users. Click for how macro headwinds and ...
1d
24/7 Wall St. on MSNMagnificent 7 Stocks Live: Trade Talks Lead To Spiking Share PricesLive Updates Live Coverage Has Ended The Magnificent 7 Could See Even More Upside 11:38 am While today’s 1,000-point Dow ...
1d
24/7 Wall St. on MSNRivian Automotive (NASDAQ: RIVN) Stock Price Prediction for 2025: Where Will It Be in 1 YearShares of Rivian Automotive (NASDAQ:RIVN) have gained 9.82% over the past five trading sessions, bringing the stock’s year-to ...
President Trump wants to lower drug prices in the U.S. by tying them to the prices paid in other developed countries. The ...
StockStory.org on MSN5d
Why Match Group (MTCH) Stock Is Falling TodayShares of dating app company Match (NASDAQ:MTCH) fell 7% in the afternoon session after the company reported weak first ...
An industry leader with significant scale, attractive margins, strong operating efficiency and long-term tailwinds. What's ...
3d
TEAMtalk on MSNThe incredible price Man Utd will sell Antony for after new LaLiga suitors pose threatMan Utd know they will make a loss on Antony despite his improved form with Real Betis - and now it's emerged how much they ...
ABC Business on MSN1d
Bunnings boasts about its price-beating guarantee but for 9,000 products there is a catchIt’s the Bunnings slogan everyone’s heard — a promise to beat a competitor’s price on the same stocked item by 10 per cent. But there’s a catch to the hardware giant’s famous price guarantee. While ...
It's not uncommon for major supermarkets to have a house brand for their products, but few if any can match the brand loyalty ...
Long-threatened tariffs from U.S. President Donald Trump have plunged the country into trade wars abroad — all while on-again ...
Cytokinetics' PDUFA date for aficamten was extended to December 26th of 2025, due to the FDA's need to review a submitted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results